CARBAMAZEPINE

Product NDC: 50090-2161
11-digit product format: 500902161
Labeler code: 50090
Product ID: 50090-2161_5c28bb65-9313-40e2-9630-cd3302dd3f94
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: CARBAMAZEPINE
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA075948
Marketing category: ANDA
Marketing start: 2002-09-01
Marketing end: 0000-00-00
Substance: CARBAMAZEPINE
Active strength: 200 mg/1
Pharmacologic classes: Decreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50090-2161		I	Inactivated by FDA	2026-08-03
excluded package	package	50090-2161	50090-2161-0	I	Inactivated by FDA	2026-08-03
excluded package	package	50090-2161	50090-2161-1	D	Discontinued by firm	2026-08-03
excluded package	package	50090-2161	50090-2161-3	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 57 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-2161-1	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-2161-0	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-2161-3	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-2161-1	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-2161-0	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-2161-3	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-2161-1	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-2161-0	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-2161-3	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-2161-1	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-2161-0	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-2161-3	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-2161-1	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-2161-0	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-2161-3	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-2161-1	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-2161-0	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-2161-3	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-2161-1	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-2161-0	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-2161-3	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-2161-1	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-2161-0	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-2161-3	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-2161-1	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-2161-0	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-2161-3	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-2161-1	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-2161-0	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-2161-3	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-2161-1	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-2161-0	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-2161-3	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-2161-1	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-2161-0	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-2161-3	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-2161-0	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-2161-3	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-2161-0	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-2161-3	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-2161-0	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-2161-3	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075948-001	CARBAMAZEPINE	CARBAMAZEPINE	200MG	TABLET / ORAL	AB		2002-02-27

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A075948-001	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A075948-001	CARBAMAZEPINE	200MG	TABLET / ORAL	AB	2002-02-27	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A075948-001	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075948-001	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075948-001	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075948-001	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075948-001	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075948-001	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075948-001	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075948-001	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075948-001	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075948-001	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075948-001	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075948-001	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075948-001	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075948-001	AB	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075948-001	AB	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075948-001	AB	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075948-001	AB	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075948-001	AB	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075948-001	AB	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075948-001	AB	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075948-001	AB	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075948-001	AB	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075948-001	AB	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075948-001	AB	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075948-001	AB	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075948-001	AB	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075948-001	AB	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075948-001	AB	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075948-001	AB	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075948-001	AB	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075948-001	AB	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075948-001	AB	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075948-001	AB	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075948-001	AB	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075948-001	AB	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075948-001	AB	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075948-001	AB	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075948-001	AB	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075948-001	AB	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A075948-001	AB	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
26452c40-1589-928d-2fae-b84a1d1cf183	Product name	9	20251105
2275add5-bc9e-431c-8e27-74c11f3127d5	Product name	1	20200728
7c710123-0208-426b-be07-b37720f2767d	Product name	1	20161206
8448f819-8511-2a70-1d0e-32e16eac918d	Product name	1	20140508
fee3eefd-cade-4e53-89b7-9d28964e1bc7	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-2161-0	2023-01-30	C162847	48780-1	f386c649-df7a-0266-e053-dadaa90a7c1a	CARBAMAZEPINE TABLETS, USP 200 mg
50090-2161-1	2023-01-30	C162847	48780-1	f386c649-df7a-0266-e053-dadaa90a7c1a	CARBAMAZEPINE TABLETS, USP 200 mg
50090-2161-3	2023-01-30	C162847	48780-1	f386c649-df7a-0266-e053-dadaa90a7c1a	CARBAMAZEPINE TABLETS, USP 200 mg

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
50090-2161-0	CARBAMAZEPINE	100 in 1 BOTTLE	TABLET	100	8
50090-2161-1	CARBAMAZEPINE	60 in 1 BOTTLE	TABLET	60	8
50090-2161-3	CARBAMAZEPINE	28 in 1 BOTTLE	TABLET	28	8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-2161-0	EA - Each	50090-2161	c16d3e8d-a081-4c50-b6e0-5563d2899a36	1	2019-02-13
50090-2161-1	EA - Each	50090-2161	71abd89f-ae36-44c3-905d-fc2e2e89c49e	1	2019-02-13
50090-2161-3	EA - Each	50090-2161	a7e77d2f-b954-454f-aae6-dc7cd466f323	1	2018-11-06

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-2161	CARBAMAZEPINE TABLET [A-S MEDICATION SOLUTIONS]	8	Legacy NDC, 3 package rows	20200121_3554a0b6-ea96-4516-81d7-cc2d27b4fc33.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 9 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
CARBAMAZEPINE	CARBAMAZEPINE	REMEDYREPACK INC.	52cf3ba9-0a7c-4809-830e-af93d1532726	2026-05-05	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Bryant Ranch Prepack	34f57a68-57ad-57f1-e063-6394a90a3d33	2026-03-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Preferred Pharmaceuticals Inc.	32dc301e-881d-47b0-ad16-f9ff31d19324	2026-03-20	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Golden State Medical Supply, Inc.	9fca7d59-dd9e-4fd8-bf34-e2f7e5a36801	2025-11-25	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Apotex Corp.	bf0d012f-da14-8ce3-d74f-56172cddebc5	2025-10-10	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Bryant Ranch Prepack	45b355e6-9c19-4138-a1f8-53508e88f5a9	2025-07-28	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
Carbamazepine	CARBAMAZEPINE	American Health Packaging	1dd3d934-efee-4fdb-ae6f-f47b61831a2e	2024-10-22	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Proficient Rx LP	bf61798e-c07e-4959-909a-2b4c2c83b532	2019-10-01	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948
CARBAMAZEPINE	CARBAMAZEPINE	Aphena Pharma Solutions - Tennessee, LLC	c1fc31ef-6b2e-4de4-a185-ec44e94e7b40	2016-06-02	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (ANDA): 075948 application number: ANDA075948

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
33CM23913M	CARBAMAZEPINE	298-46-4	CARBAMAZEPINE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
308979	carBAMazepine 200 MG Oral Tablet	PSN	3554a0b6-ea96-4516-81d7-cc2d27b4fc33	8
308979	carbamazepine 200 MG Oral Tablet	SCD	3554a0b6-ea96-4516-81d7-cc2d27b4fc33	8

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-2161-0	50090216100	100 TABLET in 1 BOTTLE (50090-2161-0)	100 tablet	2015-10-21	0000-00-00	No	No	Current
50090-2161-1	50090216101	60 in 1 BOTTLE						Historical
50090-2161-3	50090216103	28 TABLET in 1 BOTTLE (50090-2161-3)	28 tablet	2015-10-21	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
CARBAMAZEPINE TABLETS, USP 200 mg	A-S Medication Solutions	2020-01-18	HUMAN PRESCRIPTION DRUG LABEL	8